ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

George Church, CRISPR Pioneer, Embraces Alternative Tech In Project To Recode A Human Genome – Yahoo News

Yahoo NewsGeorge Church, CRISPR Pioneer, Embraces Alternative Tech In Project To Recode A Human GenomeYahoo NewsGeorge Church, a Harvard scientist who pioneered the use of the enzyme CRISPR to edit the genes of human cells, will use an alternative, old… Continue reading

2018-05-02 Michael Zand NEWS

Humanigen Announces Preclinical Findings Presented on Lenzilumab’s Potential to Optimize CAR-T Therapy – Nasdaq

Continue reading

2018-05-02 Michael Zand NEWS

Humanigen Announces Preclinical Findings Presented on Lenzilumab’s Potential to Optimize CAR-T Therapy – GlobeNewswire (press release)

Humanigen Announces Preclinical Findings Presented on Lenzilumab’s Potential to Optimize CAR–T Therapy
Nasdaq
Lenzilumab effectively neutralizes GM-CSF. CAR–T cells maintained robust anti-tumor activity in combination with lenzilumab. GM-CSF depletion by lenzilumab may increase CAR-T expansion. BRISBANE, Calif., May 02, 2018 (GLOBE NEWSWIRE) — Humanigen, Inc …

and more »

Continue reading

2018-05-02 Michael Zand NEWS

Hackensack Meridian Health Joins NJII’s Cell and Gene Therapy Development Center – PR Newswire (press release)

Humanigen Announces Preclinical Findings Presented on Lenzilumab’s Potential to Optimize CAR–T Therapy
GlobeNewswire (press release)
Lenzilumab effectively neutralizes GM-CSF. CAR–T cells maintained robust anti-tumor activity in combination with lenzilumab. GM-CSF depletion by lenzilumab may increase CAR-T expansion. BRISBANE, Calif., May 02, 2018 (GLOBE NEWSWIRE) — Humanigen, Inc …

and more »

Continue reading

2018-05-02 Michael Zand NEWS

Hackensack Meridian Health Joins NJII’s Cell and Gene Therapy Development Center – PR Newswire (press release)

Hackensack Meridian Health Joins NJII’s Cell and Gene Therapy Development Center
PR Newswire (press release)
NEWARK, N.J., May 2, 2018 /PRNewswire/ — The New Jersey Innovation Institute (NJII), an NJIT Corporation, has announced that Hackensack Meridian Health has joined its Cell and Gene Therapy Development Center to access the center’s process development …

and more »

Continue reading

2018-05-02 Michael Zand NEWS

Evotec Licenses CRISPR-Cas9 Technology From ERS – GenomeWeb

Hackensack Meridian Health Joins NJII’s Cell and Gene Therapy Development Center
PR Newswire (press release)
NEWARK, N.J., May 2, 2018 /PRNewswire/ — The New Jersey Innovation Institute (NJII), an NJIT Corporation, has announced that Hackensack Meridian Health has joined its Cell and Gene Therapy Development Center to access the center’s process development …

and more »

Continue reading

2018-05-02 Michael Zand NEWS

The immunotherapy prize! – Science Advances

The immunotherapy prize!Science AdvancesThe idea of stimulating the immune system to recognize and destroy cancer is more than 100 years old, but the development of effective immunotherapies has been challenging. The breakthrough came from the work of … Continue reading

2018-05-02 Michael Zand NEWS

The immunotherapy prize! – Science Advances

Science AdvancesThe immunotherapy prize!Science AdvancesThe idea of stimulating the immune system to recognize and destroy cancer is more than 100 years old, but the development of effective immunotherapies has been challenging. The breakthrough came f… Continue reading

2018-05-02 Michael Zand NEWS
  • 1
  • …
  • 156
  • 157
  • 158
  • 159
  • 160
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Evotec Licenses CRISPR-Cas9 Technology From ERS
GenomeWeb
NEW YORK (GenomeWeb) – Evotec said today that it has licensed CRISPR-Cas9 technology from ERS Genomics, expanding its existing service offering in the gene-editing space. The new license from ERS adds to Evotec’s existing CRISPR licenses from the Broad …

and more »